Association Between Duration of Dual Antiplatelet Therapy and Angiographic Multivessel Disease on Outcomes in Patients Treated With Newer-Generation Drug-Eluting Stents | Zendy

SeungYul Lee | Zendy; MyeongKi Hong | Zendy; DongHo Shin | Zendy; JungSun Kim | Zendy; ByeongKeuk Kim | Zendy; YoungGuk Ko | Zendy; Donghoon Choi | Zendy; Yangsoo Jang | Zendy; HyoSoo Kim | Zendy; Marco Valgimigli | Zendy; Antonio Colombo | Zendy; Martine Gilard | Zendy; Tullio Palmerini | Zendy; Gregg W. Stone | Zendy

Open Access

Association Between Duration of Dual Antiplatelet Therapy and Angiographic Multivessel Disease on Outcomes in Patients Treated With Newer-Generation Drug-Eluting Stents

Author(s) -

SeungYul Lee,

MyeongKi Hong,

DongHo Shin,

JungSun Kim,

ByeongKeuk Kim,

YoungGuk Ko,

Donghoon Choi,

Yangsoo Jang,

HyoSoo Kim,

Marco Valgimigli,

Antonio Colombo,

Martine Gilard,

Tullio Palmerini,

Gregg W. Stone

Publication year - 2016

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.116.004256

Subject(s) - medicine , myocardial infarction , hazard ratio , cardiology , coronary artery disease , drug eluting stent , diabetes mellitus , stroke (engine) , confidence interval , adverse effect , percutaneous coronary intervention , mechanical engineering , engineering , endocrinology

There is general agreement that the optimal duration of dual antiplatelet therapy (DAPT) in patients treated with drug-eluting stents should be individualized. We hypothesized that the extent of coronary artery disease may affect the clinical outcomes of DAPT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research